SCHEMBL29720448

SCHEMBL29720448

COC[C@@H]1CCN(c2nc(-c3ccccn3)nc3sc(-c4ccn(C(C)C)n4)c(C)c23)C1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 2/20 0.35
▸ HIF1A Q16665 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ADORA2B P29275 2/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ TRPM8 Q7Z2W7 1/20 0.33
▸ SYK P43405 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24127737 1.00 PDE10A (0.35) PDE10AHIF1ACHRM4ADORA2AADORA1
SCHEMBL29720410 0.94 HIF1A (0.33) PDE10AHIF1ANPSR1ALDH1A1KDM4E
SCHEMBL24127729 0.94 HIF1A (0.33) PDE10AHIF1ANPSR1ALDH1A1KDM4E
SCHEMBL26038290 0.90 HIF1A (0.37) HIF1ANPSR1ALDH1A1KDM4EHPGD
SCHEMBL26038980 0.89 HIF1A (0.33) HIF1ANPSR1SMN1; SMN2
SCHEMBL30481879 0.88 SYK (0.35) PDE10ACHRM4ALDH1A1KDM4EHPGD
SCHEMBL24128101 0.88 SYK (0.35) PDE10ACHRM4ALDH1A1KDM4EHPGD
SCHEMBL26038293 0.87 POLB (0.38) PDE10AHIF1AALDH1A1KDM4EHPGD
SCHEMBL24128070 0.86 KDM4E (0.34) ADORA2AADORA1NPSR1ALDH1A1KDM4E
SCHEMBL29720528 0.86 KDM4E (0.34) ADORA2AADORA1NPSR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168414-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE Shy Therapeutics LLC (US) 2023-04-26 — — EP disclosed
WO-2021257828-A9 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2022-07-21 — — WO disclosed
Send feedback